Clinical Trial Update: This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is assessing the safety and efficacy of an immune-inhibition strategy to prevent primary graft dysfunction in lung transplant recipient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Dysfunction
• Lung Injury

Snippet

Sponsor: University of California, San Francisco | Conditions: Primary Graft Dysfunction, Lung Transplantation | Phase 2 | Status: RECRUITING